Document Detail


Postoperative patterns and kinetics of cTnI, cTnT, CK-MB-activity and CK-activity after elective aortic valve replacement.
MedLine Citation:
PMID:  11759175     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: The aim of this prospective study was to evaluate postoperative kinetics of four different biochemical ischaemic markers after elective aortic valve replacement (AVR). Additionally, pre-, peri- and postoperative data were analysed in order to identify factors with possible impact on the postoperative release of the selected enzymes.
DESIGN: Forty patients (14 males, 26 females, aged 70 +/- 11 years; EF = 54 +/- 18% [mean +/- SD]) undergoing elective AVR were prospectively included in this study. For all patients, serum concentrations of cTnI, cTnT, and serum activities of CK-MB and CK were measured preoperatively as well as 0, 6, 12, 24, 48 and 120 hours after removal of the aortic cross-clamp. Clinical data were assessed in all patients and correlated with postoperative enzyme patterns.
RESULTS: There were no major complications. Preoperatively, all patients showed enzyme values in the normal range whereas the four ischaemic markers reached higher values postoperatively. cTnI reached its maximum values 24 hours (XMed = 2.35 micrograms/L, 95%-CI [2.0, 3.3]) and cTnT 48 hours after the operation (XMed = 0.239 microgram/L, 95%-CI [0.174, 0.283]). Typical biphasic release kinetics could be demonstrated for cTnT. There was a high linear correlation between cTnI and cTnT at all sampling times. In contrast, a high linear correlation between cTnI, cTnT, and CK-MB-activity was only found 48 hours after aortic unclamping. cTnI nearly was in normal range 120 h postoperatively (XMed = 0.5 microgram/L, 95%-CI [0.2, 0.6]), whereas cTnT still remained pathologically elevated (XMed = 0.223 microgram/L, 95%-CI [0.137, 0.299]). No linear correlation was found between maximum values of the ischaemic markers postoperatively and age, gender, body surface area, ejection fraction, LV-hypertrophy, operating time, ECC time, time of cardiac arrest, lowest body temperature, perfusion pressure, cardioplegia volume, reperfusion time, postoperative septiformic circulatory instability, or ventilation time.
CONCLUSIONS: All four ischaemic markers showed individual peak characteristics and kinetics after uncomplicated AVR. In contrast to previous findings, aortic cross-clamping time had no detectable impact on postoperative peak patterns of any ischaemic marker.
Authors:
U T Opfermann; A A Peivandi; M Dahm; H Hilgenstock; G Hafner; A Loos; H Oelert
Related Documents :
19794975 - Unilateral antegrade selective cerebral perfusion in aortic surgery: clinical outcomes ...
10086545 - Does left ventricular outflow tract obstruction influence outcome of interrupted aortic...
17368285 - Penetrating ulcers of the thoracic aorta: results from a single-centre experience.
9502145 - Hemodynamics after aortic valve replacement with st. jude medical valve for patients wi...
20967435 - Percutaneous nephrolithotomy for complex caliceal and staghorn stones in patients with ...
15040025 - Comparison of long-term effects between intra-arterially delivered ethanol and gelfoam ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Swiss medical weekly     Volume:  131     ISSN:  1424-7860     ISO Abbreviation:  Swiss Med Wkly     Publication Date:  2001 Sep 
Date Detail:
Created Date:  2001-12-10     Completed Date:  2002-03-21     Revised Date:  2011-02-15    
Medline Journal Info:
Nlm Unique ID:  100970884     Medline TA:  Swiss Med Wkly     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  550-5     Citation Subset:  IM    
Affiliation:
Department of Cardiothoracic and Vascular Surgery, University Hospital of Mainz, Germany. uli.opfermann@web.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Aortic Valve / metabolism*,  surgery*
Aortic Valve Insufficiency / metabolism*,  surgery*
Aortic Valve Stenosis / metabolism*,  surgery*
Creatine Kinase / metabolism*
Creatine Kinase, BB Form
Female
Heart Valve Prosthesis*
Humans
Isoenzymes / metabolism*
Male
Middle Aged
Postoperative Period
Prospective Studies
Surgical Procedures, Elective*
Time Factors
Troponin I / metabolism*
Troponin T / metabolism*
Chemical
Reg. No./Substance:
0/Isoenzymes; 0/Troponin I; 0/Troponin T; EC 2.7.3.2/Creatine Kinase; EC 2.7.3.2/Creatine Kinase, BB Form

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence.
Next Document:  Febrile seizures and parental anxiety: does information help?